PharmTech Drug Digest 11.20
News|Articles|March 22, 2016

Pharmapack Europe Addresses Key Industry Trends

The conference discussed key industry issues including serialization, innovation, and patient-centricity.

Pharmapack Europe, a conference for the pharmaceutical packaging and drug delivery industry, discussed key industry issues including serialization, innovation, and patient centricity.

Pharmapack Europe, which took place in Paris from Feb. 10-11, 2016, addressed serialization and efforts to prevent pharmaceutical counterfeiting. The Serialization, Track & Track Symposium at the conference discussed the ongoing implementation of track-and-trace technologies, as well as the implications of the pan-European authentication scheme and its impact on contract manufacturers, offices of emergency management, and international pharmaceutical companies. The event also included an interactive exchange on anti-counterfeiting strategies, including authentication technologies to support brand protecting and supply chain integrity.

Multiple sessions and workshops at Pharmapack Europe concentrated on improving patient experience through ease-of-use, patient protection, and enhanced packaging. The conference also discussed innovation, focusing on patient compliance packaging solutions and medical polymer technologies for pharmaceutical packaging and drug delivery.

Pharmapack Europe 2016 included 367 exhibitors and 3409 visitors, representing 74 countries in total. The 2017 conference is set to take place from Feb. 1-2, 2017 in Paris.

Source: Pharmapack Europe


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.